# A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

> **NCT00333112** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 398 (actual)

## Conditions studied

- Urinary Incontinence

## Interventions

- **DRUG:** solifenacin succinate
- **DRUG:** tamsulosin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00333112
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 398 (ACTUAL)
- **Last updated:** 2014-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00333112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00333112, "A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00333112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*